Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.

AUTOR(ES)

Ivey, H H

RESUMO

Six preterm infants with a persistent ductus arteriosus, who failed to improve with conventional medical management, received indomethacin in an attempt to close the duct pharmacologically. All infants weighed less than 1000 g when the drug was administered. All showed a transient response to indomethacin; however, no infant demonstrated a permanent response, even though 5 of the 6 received multiple doses. One of the patients developed a severe episode of anuria, uraemia, and gastrointestinal bleeding. Of the 6 infants, 3 underwent subsequent successful surgical ligation of the ductus. It is suggested that the extremely preterm infant may be a 'poor responder' to indomethacin. Since the side effects of indomethacin may be life-threatening, it may be wise to consider surgical ligation in lieu of indomethacin administration in these infants.

Documentos Relacionados

• Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birthweight infants.
• Postnatal fetal and adult hemoglobin synthesis is preterm infants whose birth weight was less than 1,000 grams.
• Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response.
• Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.
• Persistent ductus arteriosus in Malaysian patients.